BUCHI J KEVIN 4
4 · Benitec Biopharma Inc. · Filed Dec 7, 2023
Insider Transaction Report
Form 4
BUCHI J KEVIN
Director
Transactions
- Award
Options (right to buy)
2023-12-06+35,000→ 35,000 totalExercise: $3.13Exp: 2033-12-06→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant.